Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company ...
Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
LeonaBio Inc. advanced stock charts by Barron's. View LONA historical stock data and compare to other stocks, and exchanges.
The process of “epigenetic memory” in nerve cells plays a key role in learning ability, memory function, and healthy brain ...
Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation ...
Neuroinfectious diseases, encephalitis, and neuroinflammation represent a diverse group of conditions that significantly ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
When it comes to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and certain forms of dementia, ...
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...
Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...
Researchers identify two key proteins that allow chandelier cells to connect with excitatory neurons. This "handshake" regulates brain signals and, when disrupted, may lead to epilepsy or autism.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback